ANI Pharmaceuticals, Inc. raised earnings guidance for the Full Year 2025. For the period, the company expects Net Revenue to be in the range of $854 million to $873 million compared to previous guidance of $818 million to $843 million.
ANI Pharmaceuticals, Inc. raised earnings guidance for the Full Year 2025. For the period, the company expects Net Revenue to be in the range of $854 million to $873 million compared to previous guidance of $818 million to $843 million.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.